Popular Weight Loss Drugs Ozempic and Wegovy Alert: FDA Adds Intestinal Blockage Warning
Portfolio Pulse from Vandana Singh
The FDA has updated the labeling for Novo Nordisk's Ozempic and Wegovy, and Eli Lilly's Mounjaro, to include warnings about reports of blocked intestines following their use. Novo Nordisk and Eli Lilly are facing a lawsuit related to claims that their medications can lead to a similar condition known as gastroparesis. The FDA's database reveals 8,571 reports of gastrointestinal disorders associated with these medications, including 33 cases of ileus, with two fatalities.
September 27, 2023 | 3:52 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Eli Lilly's Mounjaro now carries a warning about potential intestinal blockage. The company is also facing a lawsuit over similar claims.
The FDA's label update and the ongoing lawsuit could negatively impact Eli Lilly's reputation and sales of Mounjaro.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Novo Nordisk's Ozempic and Wegovy now carry warnings about potential intestinal blockage. The company is also facing a lawsuit over similar claims.
The FDA's label update and the ongoing lawsuit could negatively impact Novo Nordisk's reputation and sales of Ozempic and Wegovy.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100